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Abstract
In eukaryotes, the 3’ ends of RNA polymerase II-generated transcripts are generated in the majority of
cases  by site-specific  endonucleolytic  cleavage,  followed by  the  addition  of  a  poly(A)  tail.  Through
alternative polyadenylation, a gene can give rise to multiple mRNA isoforms that differ in the length of
their  3’  UTRs  and  hence  in  their  susceptibility  to  post-transcriptional  regulatory  factors  such  as
microRNAs. A series of recently conducted, high-throughput studies of poly(A) site usage revealed an
extensive tissue-specific control and drastic changes in the length of mRNA 3’ UTRs upon induction of
proliferation in resting cells. To understand the dynamics of poly(A) site usage, we recently identified
binding sites of the major pre-mRNA 3’ end processing factors - cleavage and polyadenylation specificity
factor  (CPSF),  cleavage  stimulation  factor  (CstF),  and  cleavage  factor  Im (CF  Im)  -  and  mapped
polyadenylation sites in HEK293 cells. Our present study extends previous findings on the role of CF Im in
alternative polyadenylation and reveals that  subunits of the CF Im complex generally control  3’ UTR
length. More specifically, we demonstrate that the loss-of-function of CF Im68 and CF Im25 but not of CF
Im59 leads to a transcriptome-wide increase of the use of proximal polyadenylation sites. 
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Introduction
Generation of mature eukaryotic mRNAs from pre-mRNAs includes addition of a 7-methylguanosine cap,
splicing out of introns and cleavage and polyadenylation of the 3’ end [1, 2, 3, 4]. Most of these processes
are  carried  out  co-transcriptionally  by a  number  of  protein  complexes and  are  completed  before  the
transcription complex reaches the end of the gene. The process of cleavage and polyadenylation which is
the focus of our work, involves a complex that contains up to 85 proteins [5]. At the core however, are a
few  smaller  subcomplexes:  the  cleavage  and  polyadenylation  specificity  factor  (CPSF),  cleavage
stimulation factor (CstF), cleavage factors Im and IIm (CF Im and CF IIm), a poly(A) polymerase (PAP) [4],
and the nuclear poly(A) binding protein 1 (PABPN1) [6].
CF Im is a tetramer composed of two 25 kDa (CF Im25) subunits and two proteins of either 59 or 68 kDa
(CF Im59 or  CF Im68) [7,  8].  It  was previously hown through SELEX analysis to preferentially bind
UGUA subsequences in the pre-mRNAs [9]. The molecular basis of this interaction emerged from recently
solved crystal structures of CF Im25 in complex with the RNA recognition motif (RRM) of CF Im68 [10,
11].  Surprisingly,  it  is  the  Nudix  hydrolase  domain  of  CF Im25 that  specifically  recognizes  UGUA,
whereas CF Im68 appears to increase the binding affinity of the complex. These structure models further
revealed that a CF Im25 dimer binds two UGUA sequences in an antiparallel manner forcing the looping
of  the  RNA sequence between the  UGUA motifs.  Yang and colleagues  proposed that  looping  might
facilitate alternative polyadenylation via CF Im [10]. The composition of individual CF Im complexes that
bind pre-mRNA molecules is not known and it is unclear whether CF Im59 and CF Im68 are functionally
interchangeable. CF Im25, CF Im59 and CF Im68 share many interaction partners and structures of the
CF Im25/CF Im59-RRM and CFIm25/CFIm68-RRM complexes suggest a nearly identical overall domain
architecture [12]. However, subtle differences between the sequences of CF Im59 and CF Im68 or amino
acid modifications not obvious in the structure could enable these proteins to establish distinct interactions
with  target  RNAs  and  carry  out  somewhat  different  functions.  Consistent  with  this  hypothesis  are
observations that CF Im59 and CF Im68 also have distinct interaction partners. CF Im68 has been shown to
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interact with the SR proteins hTra2b, Srp20 and 9G8 [13] and CF Im59 with U2AF65 [14]. In both cases
these interactions take place via serine/arginine rich (SR) domains. In addition, CF Im59 interacts with the
arginine methyltransferase PRMT2 [15, 16]. 
By cross-linking and immunoprecipitation (CLIP) followed by deep sequencing we recently mapped the
transcriptome-wide  binding  sites  of  RNA-binding  proteins  of  the  core  polyadenylation  machinery
including CF Im25, CF Im59, and CF Im68 [17]. By further quantifying cleavage and polyadenylation (CP)
site usage in HEK293 cells in which we mapped the binding sites, we showed that binding of CF I m is
predictive  for  the  choice  of  a  polyadenylation  site,  and  that  knock-down  of  CF Im68  causes  a
transcriptome-wide increase in proximal CP site use. Here we report the results of follow-up experiments,
in which we explored the effects of CF Im25 and CF Im59 knock-down, and discuss the general question of
how CF Im acts in the regulation of polyadenylation.
Transcriptome-wide analyses reveal extensive alternative polyadenylation
Alternative polyadenylation is a  fundamental  mechanism underlying eukaryotic mRNA diversity. Both
computational and biochemical approaches have been used to map pre-mRNA 3’ ends and to characterize
the proteins involved in 3’ end formation (for reviews, see [18,  19]). The recent work of Sandberg and
colleagues  [20],  demonstrating  that  proliferating  cells  express  transcripts  whose  3’  UTRs  are
systematically  shorter  compared  to  those  of  resting  cells,  incited an  upsurge  of  interest  in  this  field.
Several protocols to capture polyadenylation sites via deep sequencing have been developed, including
3SEQ [21], direct RNA sequencing (DRS) [22], 3P-Seq [23], MAPS [24], PAS-Seq [25], SAPAS [26], A-
seq [17], and PolyA-Seq [27]. A systematic effort to combine the data generated in all of these studies has
not been undertaken. However, the recent study of Babak and colleagues [27] alone resulted in a list of
280,000 human CP sites compared to a mere 150,000 sites that were known from previous work. The
advantage of these deep sequencing-based methods is that they enable us to move away from a binary
(present/absent), EST-based description [28], or a semi-quantitative, microarray-based measurement [29]
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of polyadenylation site usage in specific libraries or tissues, towards precise quantification of alternative
polyadenylation  site  use.  This  in  turn  allows  exploration  of  the  processing  mechanism  in  various
conditions and for various classes of transcripts such as the still poorly understood noncoding RNAs. 
Relationship between tissue-specific alternative polyadenylation and proliferation rate
Babak and colleagues [27] were the first to quantitatively determine CP site usage over a broad set of
tissues as well as in actively proliferating cells. To determine whether differences in CP site use between
individual tissues follow a systematic pattern, we obtained pre-processed read mappings from the NCBI
GEO archive (GSE30198), and inferred CP sites using our computational pipeline that was previously
described [17]. In total, we identified 1,047 genes with two tandem CP sites that show expression of at
least 5 tags per million in each sample investigated. Following the approach of Sandberg et al. [20], we
further computed a cell type-specific “proliferation index”. For a given sample, the proliferation index was
defined as the median z-score of the expression level of a cell cycle-associated gene [20] in the respective
sample relative to all others. The scatter plot of the proximal/distal site usage ratio against the proliferation
index for the samples in Fig. 1A shows the expected trend. First, replicate samples prepared from the same
type of cells have very similar proliferation index as well as proximal/distal CP usage. Further, tissues with
a  low proliferation  index such as  the  brain  have low proximal/distal  CP usage ratios  compared with
samples prepared from cells with high proliferation index such as the mixture of ten human cancer cell
lines (MAQC-UHR samples from the Stratagene Universal Human Reference RNA). The correlation is
however far from perfect. Proximal/distal CP site usage ratio differs quite strongly for tissues that have a
comparable proliferation index (median log10 proximal/distal ratio of -0.53 for the brain and -0.31 for
liver). Strikingly, the tissue-to-tissue differences appear to be systematic. This is illustrated more clearly in
Fig. 1B, which shows that the scatter of proximal/distal CP site usage ratios for individual genes in pairs of
brain samples forms a narrow band around the diagonal, while the brain against liver scatter shows a clear
off-diagonal  shift.  This  systematic,  transcriptome-wide  shift  in  CP  site  usage  would  be  most
parsimoniously explained by a “master regulator” that alters the CP site usage of most genes, rather than
by many individual regulators that operate on small subsets of genes. The simplest lead to follow is the
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core polyadenylation machinery or a factor that directly interacts with it. We recently demonstrated that
knock-down of  CF  Im68,  a  key  component  of  the  mammalian  polyadenylation  apparatus,  induces  a
systematic, transcriptome-wide shift to increased proximal CP site usage [17]. In this report, we further
explore the role of the individual components of CF Im in alternative polyadenylation.
Cleavage factor I as a key regulator of 3’ UTR length
New advances in high-throughput technologies also fueled the investigation of binding patterns of RNA-
binding proteins. UV crosslinking and immunoprecipitation followed by sequencing of the bound RNA
fragments allow the identification of RNA molecules targeted by the protein of interest. These methods
enable  the  mapping  of  binding  sites  with  nucleotide  level  resolution,  either  by exploiting  crosslink-
diagnostic  mutations  (in  PAR-CLIP  [30,  31]  and  HITS-CLIP  [32])  or  the  propensity  of  reverse
transcriptase to stop at crosslinked sites [33].
We recently mapped by PAR-CLIP the transcriptome-wide binding sites for CF Im25, CF Im59, and CF
Im68 proteins in HEK293 cells. We found that all components of CF Im exhibit very specific positioning
40-50  nucleotides  (nt)  upstream of  cleavage and  polyadenylation  sites.  The  underlying  cause  of  this
positional specificity seems to be two-fold. In half of the CP sites investigated the binding profile of CF Im
components can be explained by the density profile of UGUA sequence motifs, which also peaks 40-50 nt
upstream of the CP site. However, even CP sites that do not have any UGUA within the 100 upstream
nucleotides exhibit the same peak in the CF Im read density at 40-50 nt. This suggests that positioning of
CF Im on the pre-mRNA is not only governed by sequence-specific binding, but also by interactions with
other factors such as CPSF. Motif analysis revealed that CF Im CLIP reads were enriched in the UGUA
tetramer. Detailed investigation of the cross-linking pattern further showed a positional bias of individual
components of CF Im with respect to the crosslinked nucleotide. Despite the presence of two U residues
that could act as crosslinking sites when replaced by 4-thio-U in the UGUA motif, none of the CF Im
components cross-linked efficiently directly to UGUA. The weak crosslinking efficiency of CF Im59 and
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CF Im68 to UGUA may be explained in terms of the mode of interaction of CF Im inferred from recent
structural studies [10, 11], that rather suggests that CF Im25 specifically recognizes UGUA. However, the
reason for the rather weak cross-linking of CF Im25 to UGUA remains unclear; a possible explanation may
be that  the  substitution  of  U  with  4-thio-U decreases  the  affinity  of  interaction  between the  UGUA
sequence and CF Im25. In a comparison of CF Im59 and CF Im68 in complex with CF Im25 and RNA
Yang and colleagues describe the overall architecture of both complexes as nearly identical, but also point
out that  the minor differences observed could lead to different ways RNA is bound by each of these
complexes [12]. Indeed, we observed differences in the cross-linking patterns of CF Im59 and CF Im68 as
well. CF Im68 was most efficiently cross-linked immediately downstream of UGUA motifs, whereas CF
Im59 cross-linking at this position was only slightly above background. Intersection of binding profiles of
3’ end processing factors with CP site usage showed CF Im68 and CstF-64 as the most predictive factors
for CP site choice. We used A-seq to quantify the effect of the knock-down of these two factors on CP site
choice and found that CF Im68 but not CstF-64 loss-of-function led to a transcriptome-wide increase in the
use of proximal CP sites (Fig. 2A) [17]. To further clarify the role of CF Im in the regulation of 3’UTR
length, we generated four additional A-seq libraries from HEK293 cells that were either grown under
standard conditions without treatment,  treated with a control  siRNA, or treated with siRNAs directed
against the CF Im25 and CF Im59 components of CF Im. We also obtained an additional A-seq sample
from a more efficient CF Im68 knock-down relative to our initial study [17] (Fig. 2D) as well as a paired
A-seq sample from cells treated with control siRNA.
We found that reduced levels of CF Im25 and CF Im68, but not of CF Im59 lead to a transcriptome-wide
increase in proximal CP site usage. These findings generalize the results of [34] to the entire transcriptome
(Fig.  2A,B) and demonstrate that  the CF Im25/CF Im68 complex globally controls 3’ UTR length by
suppression  of  proximal  CP  sites.  The  precise  molecular  mechanism  underlying  these  observations
remains to be elucidated. 
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Master regulators of 3’ UTR length
The search for master regulators of 3’UTR length has revealed additional candidates. In a recent report,
Berg and colleagues [35] proposed that the U1 snRNP, that normally protects pre-mRNAs from premature
cleavage  and  polyadenylation  [36],  becomes  limiting  when  cells  divide  rapidly,  leading  to  a  general
shortening of 3’ UTRs. They illustrated this phenomenon in neurons, in which the rapid transcriptional
boost induced by activation led to a relative decrease in U1 snRNP availability, which in turn caused
increased usage of proximal CP sites. The mechanism behind this effect remains, like in the case of CF Im,
to be characterized. 
Another recent study found that knock-down of the nuclear poly(A) binding protein PABPN1 leads to
increased usage of proximal CP sites transcriptome-wide [37]. The authors proposed a model whereby
under  normal  conditions,  PABPN1  competes  with  the  polyadenylation  machinery  for  weak  or  non-
canonical CP sites, which in the absence of PABPN1 are unmasked and processed. To investigate this
hypothesis and more specifically to test whether the CF Im component of the cleavage and polyadenylation
machinery  specifically  increases  the  selection  of  weak CP sites,  we grouped genes  according  to  the
relative strength of the most proximal relative to the most distal CP site (Fig. 2C; for the calculation of the
hexamer score, see [17]). In our previous work [17] we showed that distal sites are on average, stronger and
they are preferentially used in polyadenylation. We determined the change in proximal/distal ratio that
different categories of genes undergo upon CF Im68 and CF Im25 knock-down and found that the knock-
downs induce a similar increase in proximal/distal ratio irrespective of the relative strength of the proximal
sites. This indicates that suppression of proximal CP sites by the CF Im25/CF Im68 complex is not biased
by the “strength” of the CP site, as has been proposed for PABPN1.
Is 3’UTR length actively regulated?  
The question now arises how downregulation of CF Im25/68, U1 snRNP or PABPN1 promotes selection
of the proximal instead of distal poly(A) sites for cleavage. 
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One explanation may be that cleavage is the default behavior of the 3’ end processing machinery, most of
the  factors  in  the  complex serving to  mask polyadenylation sites  or  to  prevent  the  interaction of  the
cleavage factor with the putative polyadenylation site. This hypothesis is consistent with observations that
systematic shifts in polyadenylation sites are induced by the knock-down of several, very different factors,
but it is difficult to reconcile with observations that binding of many factors of the 3’ end processing
complex occurs predominantly at the sites where 3’ end reads are also most abundant. To explain this
paradox, we proposed in our previous study [17] that the cleavage sites that are used for cleavage under
normal conditions promote formation of specific 3’ end processing complex conformations that  allow
cleavage in spite  of  the fact  that  cleavage-inhibitory factors are present.  It  will  be very interesting to
determine whether the different factors that have been shown to suppress the use of proximal CP sites act
on different subsets of genes, whose expression is thereby coordinately regulated in specific conditions.
Possible mechanisms by which CF Im alone may modulate alternative polyadenylation are depicted in Fig
3. One alternative is that the composition of the CF Im complex is condition-dependent. Data collected so
far suggest that CF Im is a heterotetramer consisting of a CF Im25 dimer in complex with either CF Im59
or CF Im68. Coimmunoprecipitation of FLAG-CF Im59 or FLAG-CF Im68 indicates that CF Im59 and CF
Im68 can  be  present  in  the  same complex  (Fig.  3D)  with  a  CF Im25  dimer.  In  addition,  a  72 kDa
alternatively spliced form of the CF Im68 protein (CF Im72) [7] found in mammals could also take part in
and change the functionality of the CF Im complex. Thus, one way to modulate the choice of poly(A) sites
could be by changing the composition of the CF Im complex. 
Another related possibility is that binding of CF Im to its RNA targets or to protein-binding partners is
modulated  by  posttranslational  modifications.  In  fact,  phosphorylation  of  a  purified  cleavage  factor
fraction (containing CF Im and CF IIm) was found to be required for in vitro cleavage and polyadenylation
[38]. Ser166 in the RRM of CF Im68 is subject to phosphorylation, and mutation studies replacing Ser166
by aspartate, a phosphate mimic, revealed a twofold increase in RNA binding affinity of the CF Im25/CF
Im68  complex  [12].  Moreover,  CF  Im68  from  Hela  cells,  but  not  CF  Im59,  was  found  to  contain
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symmetrically dimethylated arginines and that it could be methylated at a glycine-arginine rich (GAR)
motif  in vitro by the methyltransferase PRMT5 [15].  CF Im59 from Hela cell  nuclei is  more strongly
modified  by  asymetrical  dimethylation  than  CF  Im68  and  both  proteins  can  be  dimethylated  by the
methyltransferase PRMT1 in vitro mainly at the C-terminus that is rich in arginines. However, no effects
of these modifications on protein-protein interactions or RNA binding capacity of the CF Im factors were
so far identified [15]. 
CF Im68 is not the only component of CF Im that has been found to be post-translationally modified.
Lysine residue 23 of CF Im25 is acetylated by CREB-binding protein and knock-down of CF Im68 reduced
CF Im25 acetylation suggesting that CF Im68 is needed for efficient acetylation [39]. Modulation of CF Im
binding affinity could be consistent with the RNA looping model proposed by Yang and colleagues [10].
Reduced binding of CF Im would prevent looping of alternative CP sites and enable the CP site to be
recognized and cleaved by CPSF. 
Finally, Shimazu et al. [39] also found that acetylation of CF Im25 decreases the interaction of CF Im with
poly(A) polymerase. This suggests that it may be the polyadenylation rather than the cleavage step that is
modulated by CF Im and other factors. Indeed, direct interactions of the U1 snRNP proteins U1A and U1-
70K [40, 41] as well as of the U2 snRNP-associated protein U2AF65 [14] with poly(A) polymerase were
shown to inhibit  polyadenylation of the newly cleaved pre-mRNA. This suggests that  the presence of
factors  that  are  involved  in  pre-mRNA  processing  steps  that  precede  cleavage  and  polyadenylation
suppresses polyadenylation of transcripts that were prematurely cleaved. This in turn would also suppress
the export and translation of these abortive transcripts because they would lack poly(A) tails. Northern
blots with total RNA upon RNAi-mediated knock-down of CF Im68 appear to show shortening of the
transcripts  to  proximal  cleavage sites  [15],  although  it  can  still  be  that  the  long,  non-polyadenylated
transcripts are unstable. 
The availability of technologies for exploring the entire transcriptome of a cell at once brought a new
appreciation  of  the  complexity of  regulation of  gene expression.  At the  same time,  they allow us to
identify biologically relevant patterns, taking advantage of the possibly very small responses of a large
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number of genes. It will be exciting to see new applications of this approach in the field of RNA 3’ end
processing.
Methods
A-seq
A-seq was carried out as described [17] with the exception of the partial RNA fragmentation step, which
consisted of alkaline hydrolysis instead of RNase I digestion. To this end, poly(A) containing RNA was
released from (dT)25-Dynabeads in 35  l 5 mM Tris-Cl pH 8.0. 70  l alkaline hydrolysis buffer was
added. Hydrolysis buffer is 50 mM Na-CO3, 1 mM EDTA, pH 9.2 and was prepared by mixing 1 ml 0.1 M
Na2CO3 with 9 ml 0.1 M NaHCO3, adding EDTA to 1 mM, adjusting the pH to 9.2 and the volume to 20
ml with H2O. The reactions are incubated for exactly 7 minutes at 95 °C. Reactions were chilled on ice
and 500 l lysis buffer of the mRNA-DIRECT kit (Invitrogen) were added. The Dynabeads from the first
step were recycled to bind the fragmented RNA that still contains poly(A). After washing the beads with
buffers  A  and  B,  the  protocol  continues  with  5’  end  phosphorylation  as  described  [17].  The  Gene
Expression Omnibus (GEO) accession number for the A-seq data is GSEXXXXX.
RNAi
Silencer  Select  siRNAs  (Ambion)  were  used  for  knock-downs  of  CF Im25  (S224836)  and  CF  Im59
(S21772). For RNAi with CF Im68 a double stranded RNA oligo with sequence 5’-NNG ACC GAG AUU
ACA UGG AUA-3’ was obtained from Dharmacon. As a negative control the oligo 5’-AGG UAG UGU
AAU CGC CUU GTT-3’ (1491991) from Microsynth was used. RNAiMax transfection agent (Invitrogen)
was employed according to the forward transfection method of the supplier. Cells were harvested after 3
days. 
Western blots
Flp-In-293 cells either without transgene or stably transformed with either Flag-CF Im59 or Flag-CF Im68
fusion constructs in pcDNA5 plasmids (Invitrogen) were grown to 70% confluency, harvested and frozen
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at -80 °C as pellets. Pellets were lysed in PND buffer (1xPBS, 0.5% NP-40, 1 mM DTT and “cOmplete”
protease inhibitor (Roche) and sonicated for 10-20 sec. 30 g of protein from the lysates of was loaded
onto 10% SDS gels. In addition, lysate containing 50 g of protein was co-immunoprecipitated with anti-
Flag  antibody (M2 monoclonal  from Sigma)  coupled  to  magnetic  protein-G Dynabeads  (Invitrogen).
Beads were washed 3x with PND buffer containing 0.1% NP-40. Bound proteins were released by heating
to 90 °C in NUPAGE LDS sample buffer (Invitrogen) containing 0.1 M DTT. Lysates and supernates from
co-IP after magnetic retention were loaded on the SDS gel, blotted to ECL membrane (GE Healthcare),
filters were probed with anti-CFIm antibody [7] and further processed with the ECL system (Invitrogen).
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Figure 1. Comparison of proximal/distal CP usage ratios of 1,047 human genes with two tandem CP sites
in tissues covered by the data set of Derti and colleagues [27]. (A) Scatter plot relating proliferative index
(x-axis) to CP site usage (y-axis) (see text for the computation of these quantities). (B) Scatter plots of
proximal/distal CP usage ratios in brain, liver and MAQC-brain samples. The grey scale indicates the
density of data points representing individual genes. Numbers in the insets represent the proportion of
points above and below the diagonal that indicates identical proximal/distal CP usage ratio for a gene in
the two tissues.
Figure 2. Changes in cleavage and polyadenylation site usage upon knock-down of CF Im components and
of CstF-64 in HEK 293 cells. A total of 3,821 transcripts with 2, 3 or 4 tandem CP sites (inferred based on
the A-seq sequence data [17] and located in the same 3’ UTR exon) whose expression was estimated to be
at least five A-seq tags per million in both untreated samples were selected. (A) Data sets were described
in [17] . An additional CF Im68 knock-down data set (marked by the asterisk) was generated in this study.
(B) Comparison of CP site usage in CF Im25 and CF Im59 knock-down sample relative to a control siRNA.
(C) Proximal shift in CP site usage under CF Im25 and CF Im68 knock-down conditions as a function of
the relative strength of the proximal CP site. Genes were divided into three subsets based on the ratio of
hexamer scores [17] of the most proximal and most distal CP sites. Within each subset, we computed the
proximal/distal CP usage ratio in a knock-down compared to the corresponding control siRNA-treated
sample.  Box-plots summarize the distribution of proximal/distal  CP usage ratio for all genes within a
particular  subset  and  a  particular  sample.  P-values  of  the  t-test  comparing  the  means  of  the  two
distributions are shown above the box-plots. (D) Western blots showing the efficiency of CF Im25, CF
Im68 and CF Im59 knock-downs.
Figure 3. Possible models of modulation of alternative polyadenylation by CF Im. (A) High concentration
of CF Im68 relative to CF Im59 leads to suppression of proximal CP sites. (B) Overall low levels of CF Im
and hence low abundance of CF Im25/CF Im68 promote cleavage and polyadenylation at proximal sites.
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(C)  Post-translational  modifications  modulate  RNA  and  protein  interactions  of  CF  Im.  (D)  Co-
immunoprecipitation  experiments  with  FLAG-CF Im59 and  FLAG-CF Im68  indicate  that  the  FLAG-
tagged CFIm proteins can randomly bind both CF Im59 and CF Im68 (and in addition CF Im72) and
possibly also form dimers of the Flag-tagged versions. Asterisks mark FLAG-tagged proteins.
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